Related Experiment Video
Updated: Jan 3, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Associations between IL-6 and Echo-Parameters in Patients with Early Onset Coronary Artery Disease
Natalia Pauli1, Kamila Puchałowicz2, Agnieszka Kuligowska2
1Department of Cardiology, Regional Hospital, 66-400 Gorzow Wielkopolski, Poland.
Insights
Interleukin 6 (IL-6) levels in early onset coronary artery disease (CAD) patients correlate with cardiac function, suggesting potential prognostic benefits. Further observation of IL-6 may aid in managing right ventricular remodeling and left ventricular systolic dysfunction.
Area of Science:
- Cardiology
- Immunology
- Biochemistry
Background:
- Interleukin 6 (IL-6) is implicated in coronary artery disease (CAD) pathogenesis.
- Early-onset CAD patients present unique characteristics compared to older individuals.
- The role of IL-6 in young CAD patients requires further elucidation.
Purpose of the Study:
- To investigate the relationship between IL-6 levels and inflammation, atherosclerosis, and cardiac function in early-onset CAD.
- To analyze the specific associations in patients with CAD manifesting at a young age.
Main Methods:
- A cohort of 100 early-onset CAD patients and 50 healthy controls were studied.
- Plasma IL-6 levels were measured alongside biochemical, anthropometric, and echocardiographic parameters.
- Arterial Doppler ultrasound was utilized for vascular assessment.
Main Results:
- No significant difference in plasma IL-6 was found between early-onset CAD patients and controls.
- IL-6 levels showed a negative correlation with ascending aorta diameter.
- IL-6 was also negatively correlated with left ventricular shortening fraction and right ventricular end-diastolic diameter.
Conclusions:
- Plasma IL-6 is associated with cardiac function parameters in early-onset CAD.
- IL-6 may contribute to right ventricular remodeling and left ventricular systolic dysfunction.
- Monitoring IL-6 levels could offer prognostic insights post-acute coronary syndrome.
Background:
Over the last two decades, many studies have investigated the association between interleukin 6 (IL-6) and pathogenesis and progression of coronary artery disease (CAD). Patients with CAD manifested at a young age are a particularly interesting group. They differ from older patients, not only in terms of the severity of coronary artery atherosclerosis, but also risk factor profiles, short- and long-term prognosis after myocardial infarction (MI). The role of IL-6 in younger patients with CAD is less well-known. Therefore, our study aimed to analyze the relationship between IL-6 level and other inflammations, atherosclerosis, and cardiac function parameters in early onset CAD patients.
Methods:
The study covered 100 patients with early onset CAD and a group of 50 healthy participants. Plasma levels of IL-6 and basic biochemical parameters, anthropometric, echocardiographic, and arteries Doppler ultrasound measurements were performed.
Results:
We did not observe a significant difference in IL-6 concentration in plasma between patients with early onset CAD and a control group, but IL-6 level was negatively correlated with echocardiographic measurements of ascending aorta diameter, left ventricular shortening fraction, and right ventricular end-diastolic diameter in our patients.
Conclusions:
In patients with early onset CAD, plasma IL-6 level is associated with other inflammation parameters and with cardiac function, potentially contributing to right ventricular remodeling and left ventricular systolic dysfunction. This suggests possible prognostic benefits of long-time observation of IL-6 level after the acute coronary syndrome.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

